|
US4925572A
(en)
*
|
1987-10-20 |
1990-05-15 |
Pall Corporation |
Device and method for depletion of the leukocyte content of blood and blood components
|
|
US4880548A
(en)
*
|
1988-02-17 |
1989-11-14 |
Pall Corporation |
Device and method for separating leucocytes from platelet concentrate
|
|
EP0341904B1
(en)
*
|
1988-05-09 |
1995-03-29 |
Temple University of the Commonwealth System of Higher Education |
Method for predicting the effectiveness of antineoplastic therapy in individual patients
|
|
US5210015A
(en)
*
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
|
US5474909A
(en)
*
|
1992-08-07 |
1995-12-12 |
Anticancer, Inc. |
Noncolorimetric histoculture method for predicting drug response of tumors
|
|
US7625697B2
(en)
*
|
1994-06-17 |
2009-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for constructing subarrays and subarrays made thereby
|
|
US5491063A
(en)
*
|
1994-09-01 |
1996-02-13 |
Hoffmann-La Roche Inc. |
Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
|
|
PT938320E
(pt)
*
|
1996-03-26 |
2010-09-22 |
Michael S Kopreski |
Método que permite a utilização de arn extracelular extraído de plasma ou de soro para detectar, monitorizar ou avaliar o cancro
|
|
US5683698A
(en)
|
1996-08-02 |
1997-11-04 |
New England Deaconess Hospital |
Formulation for alleviating symptoms associated with arthritis
|
|
US7514232B2
(en)
*
|
1996-12-06 |
2009-04-07 |
Becton, Dickinson And Company |
Method for detecting T cell response to specific antigens in whole blood
|
|
US20020006613A1
(en)
*
|
1998-01-20 |
2002-01-17 |
Shyjan Andrew W. |
Methods and compositions for the identification and assessment of cancer therapies
|
|
WO2000076492A1
(en)
*
|
1999-06-15 |
2000-12-21 |
Nutri-Logics, Inc. |
Nutrient formulations for disease reduction, and related treatment and component screening methods
|
|
US6692916B2
(en)
*
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
US20020048566A1
(en)
*
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
|
US7374881B2
(en)
*
|
2000-10-31 |
2008-05-20 |
Hitachi Chemical Research Center, Inc. |
Method for collecting and using nuclear mRNA
|
|
US20020182274A1
(en)
*
|
2001-03-21 |
2002-12-05 |
Kung-Ming Lu |
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
|
|
CA2467629A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
|
FI20020078A7
(fi)
*
|
2002-01-15 |
2003-07-16 |
Danisco |
Immuunijärjestelmän stimulointi polydextroosilla
|
|
US6878518B2
(en)
*
|
2002-01-22 |
2005-04-12 |
The Trustees Of The University Of Pennsylvania |
Methods for determining steroid responsiveness
|
|
WO2003091407A2
(en)
*
|
2002-04-24 |
2003-11-06 |
Hitachi Chemical Research Center, Inc. |
Device and method for high-throughput quantification of mrna from whole blood
|
|
US7745180B2
(en)
*
|
2002-04-24 |
2010-06-29 |
Hitachi Chemical Co., Ltd. |
Device and method for high-throughput quantification of mRNA from whole blood
|
|
AU2003261366A1
(en)
*
|
2002-08-05 |
2004-02-23 |
The Wistar Institute |
Methods for regulating brca1-brca2-containing complex activity
|
|
GB0219642D0
(en)
*
|
2002-08-23 |
2002-10-02 |
Gauthier Pierre |
Method and device for preparing tissues sections
|
|
AU2002953533A0
(en)
*
|
2002-12-24 |
2003-01-16 |
Arthron Limited |
Fc receptor modulating compounds and compositions
|
|
EP1776471B9
(en)
*
|
2004-05-25 |
2013-12-18 |
Hitachi Chemical Company, Ltd. |
Method of measuring cancer susceptibility
|
|
ATE493515T1
(de)
*
|
2005-06-08 |
2011-01-15 |
Hitachi Chemical Res Ct Inc |
Verfahren zur vorhersage der immunreaktion auf neoplastische krankheiten auf der grundlage des mrna-ausdrucksprofil in neoplastischen zellen und stimulierten leukozyten
|
|
US7935482B2
(en)
*
|
2005-09-27 |
2011-05-03 |
Source Precision Medicine, Inc. |
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
|
|
JP5027209B2
(ja)
*
|
2006-04-07 |
2012-09-19 |
日立化成工業株式会社 |
クローン病患者の末梢血白血球におけるＴ細胞受容体介在性腫瘍壊死因子スーパーファミリー及びケモカインのｍＲＮＡ発現の増強
|
|
WO2009070442A2
(en)
*
|
2007-11-14 |
2009-06-04 |
Hitachi Chemical Co. Ltd. |
Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes
|
|
WO2007117589A2
(en)
*
|
2006-04-07 |
2007-10-18 |
Hitachi Chemical Co., Ltd. |
Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
|
|
EP2015783A4
(en)
*
|
2006-05-08 |
2010-07-21 |
Hitachi Chemical Co Ltd |
METHOD FOR TESTING THE SENSITIVITY OF A MEDICINAL PRODUCT IN SOLID TUMORS BY QUANTIFYING THE EXPRESSION OF mRNA IN THIN CUTS OF TUMOR TISSUE
|
|
US20090215064A1
(en)
*
|
2008-02-27 |
2009-08-27 |
Hitachi Chemical Co., Ltd. |
Quantitative assessment of individual cancer susceptibility by measuring dna damage-induced mrna in whole blood
|